IDEXX Laboratories Inc
NASDAQ:IDXX

Watchlist Manager
IDEXX Laboratories Inc Logo
IDEXX Laboratories Inc
NASDAQ:IDXX
Watchlist
Price: 417.24 USD -0.31% Market Closed
Market Cap: 34.2B USD
Have any thoughts about
IDEXX Laboratories Inc?
Write Note

Wall Street
Price Targets

IDXX Price Targets Summary
IDEXX Laboratories Inc

Wall Street analysts forecast IDXX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IDXX is 495.39 USD with a low forecast of 409.17 USD and a high forecast of 594.3 USD.

Lowest
Price Target
409.17 USD
2% Downside
Average
Price Target
495.39 USD
19% Upside
Highest
Price Target
594.3 USD
42% Upside

IDXX Last Price Targets
IDEXX Laboratories Inc

The latest public price target was made on Jun 24, 2024 by Jonathan Block from Stifel Nicolaus , who expects IDXX stock to rise by 22% over the next 12 months. You can read more about this price target by viewing the article on TheFly.

Analyst Price Target Date Article
Jonathan Block
Stifel Nicolaus
510 USD
Upside 22%
4 months ago
Jun 24, 2024
Idexx Laboratories price target lowered to $510 from $520 at Stifel
TheFly
Unknown Analyst
Barclays
590 USD
Upside 41%
1 year ago
Feb 8, 2023
Barclays Maintains Overweight on IDEXX Laboratories, Raises Price Target to $590
Benzinga
Unknown Analyst
J.P. Morgan
550 USD
Upside 32%
1 year ago
Feb 7, 2023
JP Morgan Maintains Overweight on IDEXX Laboratories, Raises Price Target to $550
Benzinga
Unknown Analyst
Atlantic Equities
600 USD
Upside 44%
1 year ago
Feb 7, 2023
Atlantic Equities Maintains Overweight on IDEXX Laboratories, Raises Price Target to $600
Benzinga
Unknown Analyst
Citigroup
268 USD
Downside 36%
1 year ago
Feb 2, 2023
Citigroup Maintains Buy on IDEX, Lowers Price Target to $268
Benzinga
Unknown Analyst
Oppenheimer
247 USD
Downside 41%
1 year ago
Feb 2, 2023
Oppenheimer Maintains Outperform on IDEX, Raises Price Target to $247
Benzinga
Show More Price Targets
Show Less Price Targets
Jonathan Block
Stifel Nicolaus
Price Target 510 USD
Upside/Downside 22%
View Source
Unknown Analyst
Barclays
Price Target 590 USD
Upside/Downside 41%
View Source
Unknown Analyst
J.P. Morgan
Price Target 550 USD
Upside/Downside 32%
View Source
Unknown Analyst
Atlantic Equities
Price Target 600 USD
Upside/Downside 44%
View Source
Unknown Analyst
Citigroup
Price Target 268 USD
Upside/Downside 36%
View Source
Unknown Analyst
Oppenheimer
Price Target 247 USD
Upside/Downside 41%
View Source
Show More Price Targets
Show Less Price Targets
IDEXX Laboratories Inc Competitors:
Price Targets
1302
LifeTech Scientific Corp
88% Upside
METN
Metall Zug AG
61% Upside
CREO
Creo Medical Group PLC
253% Upside
MASI
Masimo Corp
0% Downside
KRMD
Repro Med Systems Inc
19% Upside
688351
Shanghai MicroPort EP Medtech Co Ltd
52% Upside
STE
STERIS plc
20% Upside
335890
Viol Co Ltd
78% Upside

Revenue
Forecast

Revenue Estimate
IDEXX Laboratories Inc

For the last 8 years the compound annual growth rate for IDEXX Laboratories Inc's revenue is 11%. The projected CAGR for the next 3 years is 8%.

11%
Past Growth
8%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
IDEXX Laboratories Inc

For the last 8 years the compound annual growth rate for IDEXX Laboratories Inc's operating income is 17%. The projected CAGR for the next 3 years is 11%.

17%
Past Growth
11%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Net Income
Forecast

Net Income Estimate
IDEXX Laboratories Inc

For the last 8 years the compound annual growth rate for IDEXX Laboratories Inc's net income is 20%. The projected CAGR for the next 3 years is 11%.

20%
Past Growth
11%
Estimated Growth
Estimates Accuracy
7%
Average Beat

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is IDXX's stock price target?
Price Target
495.39 USD

According to Wall Street analysts, the average 1-year price target for IDXX is 495.39 USD with a low forecast of 409.17 USD and a high forecast of 594.3 USD.

What is IDEXX Laboratories Inc's Revenue forecast?
Projected CAGR
8%

For the last 8 years the compound annual growth rate for IDEXX Laboratories Inc's revenue is 11%. The projected CAGR for the next 3 years is 8%.

What is IDEXX Laboratories Inc's Operating Income forecast?
Projected CAGR
11%

For the last 8 years the compound annual growth rate for IDEXX Laboratories Inc's operating income is 17%. The projected CAGR for the next 3 years is 11%.

What is IDEXX Laboratories Inc's Net Income forecast?
Projected CAGR
11%

For the last 8 years the compound annual growth rate for IDEXX Laboratories Inc's net income is 20%. The projected CAGR for the next 3 years is 11%.

Back to Top